Serum C-X-C Chemokine Ligand 1 Levels in Patients with Systemic Sclerosis: Relationship of Clinical and Laboratory Observations to Anti-CD20 Monoclonal Antibody Administration

Objectives: To determine whether C-X-C chemokine ligand 1 (CXCL1), which is a potent neutrophil chemoattractant and activator that plays important role in inflammation, is elevated in patients with systemic sclerosis (SSc) and whether it is associated with the clinical features and disease activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawanabe, Ruriko, Yoshizaki, Ayumi, Matsuda, Kazuki M., Kotani, Hirohito, Hisamoto, Teruyoshi, Norimatsu, Yuta, Kuzumi, Ai, Fukasawa, Takemichi, Ebata, Satoshi, Yoshizaki-Ogawa, Asako, Sato, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146715/
https://www.ncbi.nlm.nih.gov/pubmed/35629314
http://dx.doi.org/10.3390/life12050646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146715/
https://www.ncbi.nlm.nih.gov/pubmed/35629314
http://dx.doi.org/10.3390/life12050646

Ejemplares similares